Pedro Barata, MD, highlights phase 3 data on 177Lu-rosopatamab tetraxetan in mCRPCByPedro Barata, MD, MSc, FACPJune 2nd 2026
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617ByBenjamin P. Saylor, Strategic Content LeadJune 2nd 2026
Tanya B. Dorff, MD, highlights early data on ABBV-969 in mCRPCByTanya B. Dorff, MD, FASCOJune 1st 2026
Kim Chi, MD, on sequencing 177Lu-PSMA-617 and docetaxel in mCRPCByKim Nguyen Chi, MD, FRCPCJune 1st 2026
PROTEUS: Apalutamide plus ADT before and after RP cuts metastasis riskByBenjamin P. Saylor, Strategic Content LeadMay 31st 2026